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Background: After the acute hospital stay, most cardiac patients in Germany are transferred for 
a 3–4-week period of inpatient cardiac rehabilitation. We aim to describe patient characteristics 
and risk factor management of cardiac rehabilitation patients with a focus on drug treatment 
and control status, differentiated by education level (low level, elementary school; intermediate 
level, secondary modern school; high level, grammar school/university).
Methods: Data covering a time period between 2003 and 2008 from 68,191   hospitalized 
patients in cardiac rehabilitation from a large-scale registry (Transparency Registry to 
  Objectify   Guideline-Oriented Risk Factor Management) were analyzed descriptively. Further, a 
  multivariate model was applied to assess factors associated with good control of risk factors.
Results: In the total cohort, patients with a manifestation of coronary artery disease (mean age 
63.7 years, males 71.7%) were referred to cardiac rehabilitation after having received percutane-
ous coronary intervention (51.6%) or coronary bypass surgery (39.5%). Statin therapy increased 
from 76.3% at entry to 88.9% at discharge, and low density lipoprotein cholesterol , 100 mg/dL 
rates increased from 31.1% to 69.6%. Mean fasting blood glucose decreased from 108 mg/dL 
to 104 mg/dL, and mean exercise capacity increased from 78 W to 95 W. Age and gender 
did not differ by education. In contrast with patients having high education, those with low 
education had more diabetes, hypertension, and peripheral arterial disease, had lower exercise 
capacity, and received less treatment with statins and guideline-orientated therapy in general. 
In the multivariate model, good control was significantly more likely in men (odds ratio 1.38; 
95% confidence interval 1.30–1.46), less likely in patients of higher age (0.99; 0.99–0.99), with 
diabetes (0.90; 0.85–0.95), or peripheral arterial disease (0.88; 0.82–0.95). Compared with a 
low level education, a mid level education was associated with poor control (0.94; 0.89–0.99), 
while high education did not have a significant effect (1.08; 0.99–1.17).
Conclusion: Patients with different levels of education treated in cardiac rehabilitation did not 
differ relevantly in terms of demographics, but did differ in some clinical aspects. With respect 
to the ultimate goal of cardiac rehabilitation, ie, optimal control of risk factors, education level 
does not play an important role.
Keywords: cardiac rehabilitation, registry, inpatients, educational level, factor analysis, risk 
factor, lipids, diabetes, hypertension
Introduction
Patients are encouraged to embark on a cardiac rehabilitation program after an acute 
  cardiac event, such as a non-ST elevation myocardial infarction (NSTEMI), ST   elevation 
myocardial infarction (STEMI) followed by coronary surgery or inter  vention, or acute 
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coronary syndrome, ie, unstable angina pectoris. This is 
  conducted in specialized and certified hospitals, and usually 
lasts 3–4 weeks.1 Intervention programs aim to increase activ-
ity levels, improve nutrition, optim  ize pharmacological ther-
apy, minimize risk factors, and address psychological issues. 
Cardiac rehabilitation is as cost-effective as coronary artery 
bypass grafting2 and can reduce mortality by up to 25%.3–5
In recent years, outcomes research on the effectiveness 
of cardiovascular inter  ventions has increasingly addressed 
socioeconomic factors, including the education level of 
patients.6,7 It has been a matter of debate as to whether 
the patient’s education affects the various phases of these 
programs (referral, intervention, and long-term follow-up). 
Previous studies have been diverse in that they have inves-
tigated different countries and settings (eg, outpatient and 
inpatient cardiac rehabilitation), are partly outdated, and 
results are heterogeneous.8
In Germany, the transfer of cardiac patients from hospital 
to the cardiac rehabilitation clinic is an established proce-
dure with low barriers. Thus, the situation allows analysis 
of therapeutic effectiveness under real practice conditions.1,9 
We used this setting to investigate whether patients in car-
diac rehabilitation with various levels of education differ in 
terms of demographic or clinical patient characteristics, risk 
factor management including drug treatment, or control of 
risk factors.
Methods
Source of data
The Transparency Registry to Objectify Guideline-Oriented 
Risk Factor Manage  ment (TROL) is a noninterventional 
program initiated in 2003 in cardiac rehabilitation clinics 
throughout Germany.10,11 Participating physicians docu-
mented cardiac rehabilitation inpatients on standardized 
case report forms. The ethics committee of the Bavarian 
Physician Chamber approved the registry, and all patients 
provided informed consent. Patient data protection was 
closely observed. We report an analysis of the 2003–2008 
dataset, which comprises 68,191 patients with information 
on education level.
Variables
During the observation period, the education level was 
documented as follows: low level education (elementary 
school, corresponding to nine-year education), mid level 
(secondary modern school, corresponding to 10-year 
education), and high level (grammar school/university, 
corresponding to at least a 13-year school education, and 
facultative university diploma). Patient characteristics were 
also recorded, ie, age, gender, body mass index, length of 
stay at the rehabi  li  tation hospital, risk factors (diabetes mel-
litus, hyperlipoproteinemia, arterial hypertension, smoking, 
family history for cardiac disease), concomitant diseases 
(peripheral arterial disease, previous stroke [first reporting 
year 2005]), systolic and diastolic blood pressure at entry 
and discharge, laboratory parameters at entry and discharge 
(total cholesterol, low density lipoprotein cholesterol, high 
density lipoprotein cholesterol, triglycerides, fasting blood 
glucose), cardiopulmonary exercise testing, and medica-
tion use at entry and discharge (statins, acetylsalicylic acid, 
beta-blockers, angiotensin-converting enzyme inhibitors, 
and other drugs).
Statistical analysis
Data are presented as absolute numbers, percentages, or 
means with standard deviations. The frequencies of categori-
cal variables in subgroups were compared by the Chi-square 
or Kruskal Wallis test. Continuous variables were compared 
by the two-tailed Wilcoxon rank sum test. No Bonferroni 
adjustment was made for this post hoc specified analysis. 
Percentages were calculated on the basis of patients with 
data for each respective parameter (ie, no percentages for 
missing values provided).
The effect of education level on risk factor control was 
evaluated in a multivariate logistic regression model includ-
ing age (in 10-year steps), gender, diabetes mellitus, smok-
ing, peripheral arterial disease, body mass index ,30 kg/m2, 
and education. The latter variable included all three levels 
(low, mid, high level education), and mid level and high 
level education were compared with low level education. 
No interaction between predictor variables was noted. The 
dependent variable was good control, defined as improvement 
of low density lipoprotein cholesterol and blood pressure 
during cardiac rehabilitation and achievement of low den-
sity lipoprotein cholesterol ,100 mg/dL and systolic blood 
pressure #130 mmHg. For each variable, the odds ratio to 
obtain good control was calculated as a point estimate and 
95% confidence interval. P values #0.05 in two-sided tests 
were considered significant. The analysis was performed 
using SAS 9.1 (SAS Institute Inc, Cary, NC).
Results
Patient demographics and characteristics
In total, 68,191 patients with information on education level 
were available. Cardiac rehabilitation was undertaken in an 
inpatient setting in 96.9% and in an outpatient setting in 
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1.3% (not reported in the remaining cases). Mean   duration 
of rehabilitation was 22.0 ± 40.2 days, with decreased 
variance in the last documented years of 2007 and 2008. 
Almost two thirds of patients were retired (60.0%). Patients 
with elementary school education were the largest group 
(59.0%), followed by secondary school education (23.6%), 
and grammar school/university degree (9.6%). Education 
was not specified in 7.7%.
Demographic and clinical characteristics are summarized 
in Table 1. The average age was 63.7 years, the proportion 
of males was 71.7%, and the mean body mass index was 
28.0 kg/m2. Cardiovascular risk factors were highly prevalent 
as expected, in particular dyslipidemia (95.6%), diabetes mel-
litus (32.8%), arterial hyper  tension (83.4%), and former or 
current smoking (45.5% and 16.8%, respectively). In addition 
to coronary artery disease, 12.2% of patients had peripheral 
arterial disease and 8.8% had a history of stroke.
Patients with STEMI were the largest group (43.3%), 
followed by NSTEMI (18.4%) and unstable angina pectoris 
(18.3%). In terms of therapy in the acute hospital setting, per-
cutaneous coronary intervention was more often reported than 
coronary artery bypass grafting (51.6% versus 39.5%, respec-
tively). Due to the large sample size, statistically significant 
differences (P , 0.0001) were noted for all demographic and 
clinical characteristics. Diabetes, previous smoking, and periph-
eral arterial disease were reported less frequently, and percuta-
neous coronary interventions more frequently, in patients with 
high education than in patients with low education.
Medication
Drug treatment at entry and discharge is shown in Table 2. In 
the overall population, statins were prescribed at entry to the 
majority of patients (any drug in 76.3%). In particular simvas-
tatin (48.9%, mean dose 28.6 mg), atorvastatin (13.7%, mean 
dose 24.3 mg) and fluvastatin (6.6%, mean dose 59.9 mg). At 
the end of cardiac rehabilitation, rates of simvastatin use had 
increased, while ator  vastatin, pravastatin, and fluvastatin use 
was reported somewhat less frequently. Overall, the mean 
dosages of these agents had slightly increased. Cholesterol 
absorption inhibitor prescriptions substantially increased dur-
ing cardiac rehabilitation (from 5.6% to 43.6%). Aspirin use 
remained nearly unchanged at a high level (at discharge 82.5%), 
while clopidogrel use alone or in combination with aspirin 
slightly decreased. Angiotensin-converting enzyme inhibitors 
and angiotensin receptor blockers were frequently used in this 
registry (73.4% and 13.9%, respectively, at discharge). By 
education level, generally no major differences were noted 
for the distribution of the various statins or the mean doses at 
entry or at discharge. However, in patients with high   education, 
lower rates of angiotensin-converting enzyme inhibitors and 
higher rates of angiotensin receptor blockers, respectively, were 
reported, along with lower rates of insulin.
Target level attainment
Lipid levels, other surrogate parameters, and target level 
attainment rates at entry and at discharge are shown in 
Table 3. In the overall population, mean total cholesterol 
at entry was 192.1 mg/dL, mean low density lipoprotein 
cholesterol was 118.8 mg/dL, mean high density lipoprotein 
cholesterol was 43.5 mg/dL, and mean triglycerides were 
160.9 mg/dL.
At discharge, lipid parameters had considerably 
improved (total cholesterol 158.0 mg/dL, mean low density 
lipoprotein cholesterol 89.4 mg/dL, mean high density 
lipoprotein cholesterol 43.9 mg/dL, and mean triglycerides 
139.1 mg/dL). Consequently, between entry and discharge, 
control of lipid parameters had improved substantially. 
At discharge, the low density lipoprotein cholesterol goal 
of ,100 mg/dL was achieved by 69.6% (entry 31.1%), 
total cholesterol ,200 mg/dL by 88.1% (entry 60.1%), 
high density lipoprotein cholesterol .50 mg/dL in women 
or .40 mg/dL in men by 46.4% (entry 44.5%), and 
triglycerides ,150 mg/dL by 66.8% (54.2% at entry). 
Mean systolic and diastolic blood pressure decreased to 
122/73 mmHg (131/77 mmHg at entry), and exercise capacity 
increased to 95 W (78 W at entry). Fasting blood glucose 
values decreased to 104 mg/dL (108 mg/dL at entry).
When assessed by education level, target attainment 
levels were slightly lower in patients with low education 
compared with those having high education (for example, low 
density lipoprotein cholesterol ,100 mg/dL in 69.0% versus 
72.0%). Effects on blood pressure or HbA1c did not differ 
substantially across groups. Exercise capacity was lower in 
patients with low education compared with high education 
(90 W versus 109 W).
Factors associated with good control
Table 4 shows the multivariate model for the association 
of various factors with good control. Good control status 
was significantly more likely in men (odds ratio 1.38), and 
less likely in the presence of higher age (0.99), diabetes 
mellitus (0.89), and peripheral arterial disease (0.88), while 
education did not have an important role (compared with 
low level education as reference; mid level 0.94, ie, slightly 
reduced odds for good control, high level 1.01, ie, with no 
significant effect).
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Discussion
TROL is one of the largest registries on cardiac rehabilita-
tion and has been used, among others, for the description 
of secular trends in the management of patients in “real-
world” rehabilitation.7 The present analysis (2003–2008) 
provides insight into the effects of education on selected 
patient characteristics, cardiac drug treatments, and risk 
factor management, and is, to our knowledge, one of only 
few studies of its kind. Regarding the main outcomes, in the 
descriptive analysis of the subgroups there were only limited 
differences between patients with low, moderate, and high 
education with respect to characteristics, drug treatment, and 
outcomes (the highly significant P values in the comparison 
of groups due to the large sample are somewhat misleading 
in this context). Considering the effect of the intervention, the 
remarkable fact is that the changes are very similar, regardless 
of the baseline differences. While patients with low education 
(compared with high education) were very similar in terms of 
age and gender, they more often had diabetes, hypertension, 
or peripheral arterial disease which might complicate their 
management. However, according to the factor analysis, the 
differences in target level achievement were only weakly 
associated with education level. Compared with low level 
education, mid level education had slightly reduced odds of 
achieving good risk factor control, and high level education 
did not change the odds significantly.
Previous research has covered all three phases of cardiac 
rehabilitation (referral stage, participation stage, long-term 
behavioral change stage), while particularly focusing on 
perceived or actual physician-related or patient-related 
barriers to inclusion of eligible patients in outpatient12 or 
inpatient cardiac rehabilitation programs.13 A comprehensive 
review was published by Jackson et al for 32 studies with 
12,804 patients,8 differen  tiated by cardiac rehabilitation 
phase. Patients were more likely to participate in cardiac 
rehabilitation programs when they were actively referred 
(physician’s endorsement of the effectiveness of such a 
program), educated, married, showed high self-efficacy, and 
when the programs were easily accessible. Patients were less 
likely to participate when they had to travel long distances to 
participate in a cardiac rehabilitation program, or experienced 
guilt over family obligations. Women were less often referred 
and participated less often, even after referral. Interestingly, 
in seven of 11 studies, high education was a positive predic-
tor of participation.14–20 No studies were available for the 
participation stage itself, and only six pertinent articles with 
no clear positive or negative predictor variables have been 
found for the long-term phase.8
Our analysis adds to the knowledge of the cardiac reha-
bilitation participation phase, and unlike other studies, it 
describes (surrogate) outcomes rather than adherence. Male 
gender was the strongest factor and was associated with a 
38% increase in good control. Female gender was consistently 
described as a negative predictor for referral in three studies, 
for participation in 13 studies, and for long-term behavioral 
change in one study (no positive predictor in any study).8 
The other factors that we found to be negatively associated 
with good control were increasing age, peripheral arterial 
disease (a marker for high cardiovascular risk as noted in 
many studies21,22), and a high body mass index ($30 kg/m2). 
Generally, the effect sizes (ie, difference of the odds ratios 
from 1) were very small for education, so the effect of this 
factor can be considered to be negligible.
Some other findings in this registry deserve consideration. 
Because guidelines for cardio  vascular disease usually focus 
on conditions, such as coronary heart disease or diabetes, 
rather than on specific settings, only few treatment goals have 
been specifically developed for cardiac rehabilitation.23 Thus, 
the target values for individual risk factors, such as lipids,24 
blood pressure,25 and blood glucose,26 and the medication 
recommendations for patients with coronary heart disease 
do not generally differ in the cardiac rehabilitation setting 
from those for patients managed by family physicians. Drug 
treatment in cardiac rehabilitation appears to have been inten-
sified in terms of drug classes, drugs, and doses compared 
with previous years.10 For example, the proportion of patients 
treated with beta-blockers and angiotensin-converting 
enzyme inhibitors/angiotensin receptor blockers was higher 
compared with previous surveys in the same setting, while 
the proportion of patients treated with statins and aspirin 
Table 4 Factors associated with good control in the multivariate 
regression model
Parameter OR 95% CI
Age (10-year intervals) 0.99 0.99, 0.99
Gender (male, female) 1.38 1.30, 1.46
Diabetes mellitus 0.90 0.85, 0.95
Current smoking 0.96 0.90, 1.02
Peripheral arterial disease 0.88 0.82, 0.95
BMI # 30 kg/m2 0.91 0.86, 0.96
Mid level educationa 0.94 0.89, 0.99
High level of educationa 1.01 0.94, 1.09
Notes:  A  total  of  49,907  observations  was  used  in  this  model.  Good  control 
was  defined  as  attainment  of  LDL-C  ,  100  mg/dL  and  blood  pressure  # 
130/80 mmHg at end of cardiac rehabilitation, and improvement of these values 
during cardiac rehabilitation. The c statistic, which measures how well the model 
predicts which parameters are more likely to result in good control, was 0.56. For 
further explanation of the model, please refer to the methods section.a Versus low 
level education.
Abbreviations: BMI, body mass index; CI, confidence interval; OR, odds ratio. 
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was stable. Further, modified treatment approaches (eg, 
combination therapy of cholesterol absorption inhibitors and 
statins) and comprehensive patient management27 seem to 
have contributed to higher control rates, eg, for cholesterol 
and its fractions.
However, when discharged from cardiac rehabilitation, 
many patients still do not meet the targets of the respec-
tive guidelines. Similar findings on suboptimal control of 
lipids,28,29 diabetes mellitus,30 and hypertension31 have been 
reported in primary care, which is the setting in which most 
patients with coronary heart disease are managed after cardiac 
rehabilitation. Reasons may include the limited time period 
in which physicians have to initiate lifestyle modifications 
or drug treatment during rehabilitation (about 3–4 weeks). 
Further possible explanations include the complexity of 
patients with coronary heart disease who often have con-
comitant diseases,32 suboptimal compliance with therapy, or 
the clinical inertia of the treating physicians.33,34
Some methodological aspects deserve consideration. 
A strength of using the registry was the consecutive inclu-
sion of unselected patients representative of routine clinical 
care with close follow-up, resulting in a small number of 
missing values. In terms of limitations, selection bias may 
have occurred, because centers participating voluntarily in 
a registry are more likely to have an interest and probably 
increased knowledge of the research question. Overall, data 
quality in a registry is not as high as in a study under Good 
Clinical Practice rules, and audits with source data verifica-
tion were performed in a limited number of centers only. With 
regard to education, categories were relatively crude, given 
that high education comprised a wide spectrum and varia-
tion of years at school or university. Owing to the post-hoc 
approach, we did not have data on certain character  istics 
reported in other analyses.
Conclusion
The present analysis provides an overview of the charac-
teristics, treatment, and risk factor control in the cardiac 
rehabilitation setting in Germany. Patients treated in cardiac 
rehabilitation with different levels of education did not differ 
relevantly in demographics, but did differ in some clinical 
aspects. Nonetheless, similar control rates could be achieved 
for low versus high education level. Thus, with respect to the 
ultimate goal of cardiac rehabilitation, ie, optimal control of 
risk factors, education background does not seem to have an 
important role. However, control of cardiovascular risk factors 
is not yet adequate and should be improved in the future.
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